Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arterial Occlusive Diseases (Phase 1)
Cerebral Palsy (Phase 1/Phase 2)
Chronic Limb-Threatening Ischemia (Phase 1)
Colorectal Neoplasms (Phase 2)
Coronary Artery Bypass (Phase 2)
Coronary Artery Disease (Phase 4)
Diabetes Mellitus (Phase 2)
End Stage Liver Disease (Phase 3)
Fibrosis (Phase 1/Phase 2)
Gynatresia (Phase 4)
Heart Failure (Phase 2)
Liver Cirrhosis (Phase 1/Phase 2)
Lymphoma (Phase 1)
Myocardial Infarction (Phase 2)
Myocardial Ischemia (Phase 3)
Neoplasms (Phase 1)
Neuroblastoma (Phase 1)
Osteonecrosis (Phase 1)
Peripheral Arterial Disease (Phase 1)
Stem Cell Transplantation (Phase 1/Phase 2)
Uterus (Phase 4)
Vascular Diseases (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
